Introduction
Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world. 1 Surgery, chemotherapy, and radiotherapy are the major conventional therapies for tumor, 2 but they are not suitable for HCC treatment because HCC is typically chemo-and radio-resistant. Moreover, these therapeutic approaches also have numerous limitations and drawbacks, such as strong systemic toxicity and complications, poor compliance, drug resistance, low-postoperative survival time, and high-recurrence rates. 3, 4 Therefore, more novel therapeutic strategies are urgently needed. Nanoparticle drug delivery systems (NDDS) have been extensively researched over the past few decades and have become the main focus in the development of cancer-targeted theranostics. 5, 6 NDDS alters the biodistribution and pharmacokinetics properties of drugs to ameliorate side effects while enhancing therapeutic effects. These positive effects occur via various mechanisms, such as specific binding to tumor or blood vessel cells, enhanced permeability and retention (EPR) effect, and utilizing the unique pathophysiology and microenvironment of tumors (such as pH-, redox-, enzyme-, or other stimuli-sensitive nanoparticles).
Glycyrrhetinic acid (GA) and glycyrrhizin (GL) are present in the roots of Glycyrrhiza glabra L. Recent studies have found that GA and GL possess pharmacological actions, such as anti-inflammatory, anti-diabetic, and anti-tumor effects. 15 Furthermore, the surface of rat hepatocyte membranes has specific binding sites for GA and GL, 16 where the number of GA-binding sites is greater than that of GL. Moreover, tumor tissues possess 1.5-to 5-fold more GA receptors than normal tissue. 17, 18 Curcumin (CUR) is a diketone compound that is derived from Curcuma longa. Modern pharmacological studies have revealed the numerous pharmacological activities of CUR, such as anti-inflammation, antioxidation, anti-cancer, and antiangiogenesis activities. 19, 20 Moreover, CUR inhibits the proliferation of HCC cells and has antiangiogenic activity against HCC cells that were implanted in nude mice. 21, 22 However, the poor water solubility and bioavailability of CUR limit its clinical applications. 23 These limitations can be addressed by hosting CUR in the mesopores of highly drug-loaded MSN.
In this study, GA was selected as a target ligand and was covalently modified on the surface of MSN (Figure 1) . The resultant glycyrrhetinic acid-functionalized mesoporous silica nanoparticle (MSN-GA) has the potential to specifically deliver drugs to HCC cells. CUR, as an insoluble anticancer drug, was 
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MsN-ga for active tumor targeting loaded into MSN-GA. The covalent bond between GA and MSN was investigated by Fourier transform infrared spectroscopy (FTIR). The characteristics and morphologies of MSN and MSN-GA were studied with transmission electron microscopy (TEM) and dynamic light scattering (DLS). HepG2 cells were selected for the investigation of the cytotoxicity and tumor cell targeting efficiency of CUR-loaded MSN-GA.
Materials and methods Materials
The following materials were obtained from commercial suppliers and used as received: CUR, GA (98%), coumarin-6, 4′,6-diamidino-2-phenylindole (DAPI), anhydrous dimethyl sulfoxide (DMSO), N-hydroxysuccinimide (NHS), N,N′-dicyclohexyl carbodiimide (DCC), cetyltrimethyl ammonium bromide (CTAB), (3- 
Preparation of MsN
MSN was synthesized in accordance with reported works. 14, 24 Briefly, CTAB (1.00 g) was added to 480 mL of deionized water. The suspension was stirred at 80.0°C until homogenous. A total of 3.5 mL NaOH (2.00 M) was added to the solution under stirring for 10 min, then 5 mL TEOS was added dropwise. The resultant reaction mixture was stirred for 3 h to yield a white precipitate. The mixture was continuously stirred at room temperature for 24 h. After centrifugation (10,000 rpm, 10 min, 25°C), the precipitate was washed six times with deionized water and ethanol, and then dried in a vacuum oven at 60.0°C.
After synthesis, 0.4 g of the as-prepared particles were briefly treated with 32 mL methanol under intensive stirring for 36 h at 60.0°C to remove the template CTAB from the MSN. Then, 0.2 mL concentrated hydrochloric acid (36.5%) was added dropwise to the above suspension. Finally, the suspension was washed six times with methanol. MSN without CTAB was vacuum-dried at 50.0°C for 24 h. synthesis of amino-functionalized MsNs (MsN-Nh 2 )
Amino-functionalized MSN (MSN-NH 2 ) was synthesized according to a published method: 0.40 g MSN and 1.50 mL APTES were added to 25 mL ethanol. 25 The mixture was stirred for 24 h at 30°C. The synthesized MSN-NH 2 was collected by centrifugation, washed six times with ethanol, and vacuum dried at 60.0°C for 24 h.
synthesis of MsN-ga MSN-GA was synthesized as follows: 0.52 g NHS, 0.94 g DCC, 1.00 g GA, and 0.50 mL triethylamine were added to 20 mL anhydrous DMSO. The reaction mixture was stirred for 24 h at 30°C in the dark. The product was filtered and washed with diethyl ether for six times to obtain the NHS ester of GA (GA-NHS) ( Figure 1 ).
Synthesized GA-NHS (60.0 mg) and MSN-NH 2 (100.0 mg) were added to 15 mL anhydrous DMSO. The mixture was stirred for 24 h at 60°C. The synthesized MSN-GA was collected by centrifugation. The unconjugated GA-NHS molecules were removed by washing MSN-GA six times with DMSO and ethanol.
loading capacity of cUr in MsN
To investigate the loading capacity of CUR on MSN, 20 mL ethanol solution of CUR (2 mg/mL) was placed in a 50-mL round-bottomed flask with 40 mg MSN. The mixture was dispersed via sonication. Then, ethanol was volatilized with a rotary evaporator at 150 rpm and 50°C. The final powder was washed with 50% ethanol (40 mL) to remove surplus CUR. The dried CUR-loaded MSN was thus acquired (MSN-CUR). The preparation of CUR-loaded MSN-GA (denoted as MSN-GA-CUR) followed the same method as MSN-CUR. Loading capacity was quantified by measuring the absorbance values of the loaded drug in the preparation with a UV-spectrophotometer (UV-5200PC; Shanghai Metash Instruments Co., Ltd., Shanghai, China) at 430 nm (Eq. (1)).
LC
Weight of CUR in preparation Weight of preparation
In vitro drug release
The in vitro release of CUR from free CUR, MSN-CUR, or MSN-GA-CUR was performed using the dialysis method. Four milliliters of different CUR-loaded preparations that contained 0.3 mg CUR was placed in a dialysis bag (MWCO 8,000 to 14,000). The dialysis bag was immersed in 100 mL 30% ethanol solution and incubated in a thermostatic water bath oscillator (Shanghai Samsung Laboratory Instrument Co., Ltd., Shanghai, China) at 37°C and 100 rpm. At set intervals, a 4-mL sample was taken and replaced with fresh dissolution medium. The sample was filtered through a 0.22-μm filter and quantified via UV-Vis spectrophotometry at 430 nm.
characterization of preparations
The FTIR spectra of MSN and MSN-GA were obtained using an FTIR spectrophotometer (Nicolet iS50; Thermo Fisher Scientific, Waltham, MA, USA) to confirm the successful synthesis of MSN-NH 2 and MSN-GA. Malvern Zetasizer Nano ZS ZEN 3600 instrument (Malvern, UK) was employed to measure the size distribution and zeta potential of different samples. TEM (Hitachi-7500, Hitachi, Tokyo, Japan) was used to observe the morphology of MSN and MSN-GA. Differential scanning calorimetry (DSC) curves were obtained using a STA449 thermal analyzer (Netzsch, Germany) in the temperature range of 20°C-300°C at a heating rate of 10°C min
.
cell culture and determination of nanoparticle cytotoxicity
The hepatocellular carcinoma HepG2 cell line was provided by Chongqing Key Laboratory of Biochemistry and Molecular Pharmacology. The cells were cultured in RPMI-1640 medium that contained 10% FBS and 1% PS in a humidified incubator with 5% CO 2 atmosphere. This research has been reviewed and approved by the institutional review board of the Chongqing Medical University. The cytotoxicity of the nanoparticles against HepG2 cells was determined by MTT assay. HepG2 cells (5×10 3 cells/well) were seeded into a 96-well plate and cultured for 24 h. Then, the cells were treated with 100 μL of fresh medium that contained CUR concentrations of 6, 12, 24, 36, 48, or 60 μg/mL. After 24 h of incubation, 20 μL MTT solution (5 mg/mL) was added per well. The cells were incubated for 4 h. Then, 150 μL DMSO was added to each well to dissolve formazan crystals. The absorbance per well was measured with an ELx800 microplate reader (Biotek Inc., Winooski, VT, USA) at 490 nm.
In vitro cellular uptake
High-performance liquid chromatography (HPLC) and confocal laser scanning microscopy (CLSM) were adopted to evaluate the in vitro uptake of various formulations by HepG2 cells. For HPLC, HepG2 cells (5×10 3 cells/well) were seeded into a six-well plate for 24 h. The cells were treated with free CUR, MSN-CUR, and MSN-GA-CUR for 4 h and then washed three times with fresh PBS solution to remove non-associated nanoparticles. Then, the cells were collected, suspended in 200 μL water, and frozen thrice. After centrifugation (12,000× g, 20 min), 1.5 mL ethyl acetate was added to the collected supernatant and vortexed. The mixture was centrifuged, and the precipitate was then collected and vacuum-dried. Aliquots of the samples were analyzed with HPLC, which was equipped with a Hypersil™ BDS C18 column (15 cm ×4.5 mm, 5 μm) and an ultravioletvisible detector set at 430 nm. The mobile phase comprised methanol/water/citric acid (73/26.7/0.3), and the flow rate was 1.0 mL/min.
For CLSM, HepG2 cells (6×10 4 cells/well) were seeded for 24 h in a 24-well plate that contained one glass coverslip per well. After 30 min of co-incubation with 100 μg/mL of coumarin-6-labeled MSN (C-6-MSN) or coumarin-6-labeled MSN-GA (C-6-MSN-GA) 37°C, the cells were washed with PBS, fixed with 3.7% formaldehyde and stained with DAPI. The glass coverslip was observed under a confocal microscope (Nikon A1R, Japan).
C-6-MSN and C-6-MSN-GA were prepared as follows: 25 mg MSN or MSN-GA were dispersed in 4 mL coumarin-6 (15 μg/mL) chloroform solution. The chloroform was then evaporated using a rotary evaporator to obtain dried C-6-MSN or C-6-MSN-GA. 
statistical analysis
Data were expressed as mean ± SD and analyzed by SPSS 13.0 software (IBM Corp., Armonk, NY, USA). P,0.05 was considered statistically significant.
Results and discussion synthesis and characterization of nanoparticles
The mesoporous silica coating was formed via the selfassembly of the surfactant template-CTAB and silica 
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MsN-ga for active tumor targeting precursor TEOS in basic solution. To generate mesopores, the template-CTAB was removed by a commonly used extraction procedure that used methanol and hydrochloric acid as solvent.
MSN-NH 2 was synthesized in anhydrous organic solvent by the condensation reaction between the silanol group in MSN and oxyethyl group in APTES.
To confirm that the template-CTAB in MSN was completely removed and that MSN-NH 2 and MSN-GA were successfully synthesized, the FTIR spectra of the samples were obtained (Figure 2) . The peaks at 2,922 cm −1 and 2,855 cm
in the spectra of MSN with CTAB were considered as the C-H stretching vibration of CTAB. These peaks disappeared in the spectra of MSN, which indicated the complete removal of the template-CTAB from MSN. All samples showed the framework absorption bands of siliceous materials, such as Si-O-Si asymmetric stretching vibration (1,085 cm were considered as the C-H stretching vibration of APTES grafted on MSN-NH 2 . These peaks implied the successful grafting of APTES on MSN (MSN-NH 2 ). In the MSN-GA spectrum, the new bands that appeared at 1,447 cm −1 and 1,700 cm −1 were assigned to the amide II band and C=O stretching, respectively. Meanwhile a new peak at 1,606 cm −1 was considered as the C=C stretching vibration of GA. These new peaks confirmed that the GA molecule was covalently grafted onto MSN through an amide bond. 26, 27 The morphology and particle size of the as-synthesized MSN and MSN-GA were characterized with TEM. The TEM images (Figure 3) showed the uniform morphology of MSN and MSN-GA with an average particle size of ~110 nm.
The zeta potential of MSN, MSN-NH 2 , and MSN-GA were measured by Malvern Zetasizer. As shown in Figure 4 , the potentials of naked MSN and MSN-NH 2 were −24±4.61 mV and −4.08±2.56, respectively. Moreover, the potential of MSN-GA changed to −25.27±0.57 when GA molecule was modified on the surface of MSN. These changes in zeta potential indirectly confirmed the successful synthesis of MSN-NH 2 and MSN-GA.
MSN-GA showed a high drug-loading capacity because of its remarkably high pore volume (0.9 cm 3 /g) and the special characteristics of MSN. 28 The LC of MSN was Figure 5 . The thermograms of CUR and the physical mixture of MSN and CUR (MSN+CUR) displayed a characteristic single-melting endothermic peak at 180°C, which disappeared in the thermograms of MSN-CUR and MSN-GA-CUR. These observations implied that the CUR was successfully incorporated into the mesoporous channels of MSN-CUR and MSN-GA-CUR and that CUR was present in a non-crystalline form.
In vitro drug release
The in vitro release profiles of CUR from MSN-CUR and MSN-GA-CUR in 30% ethanol solution were investigated. As shown in Figure 6 , only 12.9% CUR was released within 24 h from pure CUR, which revealed the poor solubility of the pure CUR crystals. However, almost 50% CUR was cumulatively released from MSN-CUR and MSN-GA-CUR within the first 8 h. These results indicated that CUR became more soluble after incorporation into MSN or MSN-GA.
Referring to the results of the above DSC analysis, the significant difference in the release profiles between CUR and MSN-CUR-GA may be attributed to the incorporation of non-crystalline CUR into the mesopores of MSN or MSN-GA. Meanwhile, the contact area between the drug and dissolution medium increased after CUR was incorporated into the MSN or MSN-GA. These results accelerated the release of CUR from both MSN-CUR and MSN-GA-CUR.
Moreover, the release of MSN-CUR and that of MSN-GA-CUR were not significantly different.
Determination of nanoparticle cytotoxicity
The cytotoxicity of MSN-GA against HepG2 cells was determined to investigate the cell targeting property of MSN-GA. As shown in Figure 7 , all CUR formulations displayed dosedependent toxicity against HepG2 cells. Free CUR had obvious cytotoxicity against HepG2 cells. MSN-CUR showed relatively higher cytotoxicity against HepG2 cells, which may be attributed to the internalization of nanoparticles into 
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MsN-ga for active tumor targeting competitive binding assay was performed in parallel. Free GA (135.73 μmol/mL) was added in advance before the addition of MSN-GA-CUR (MSN-GA-CUR+GA). The results of the GA competitive binding assay showed that the inhibitory effects of MSN-GA-CUR+GA on HepG2 cells were lower than that of MSN-GA-CUR. These effects could be caused by the competitive binding of free GA with GA receptors, thus decreasing the cellular uptake of MSN-GA-CUR. These results confirmed the specific GA receptor-mediated endocytosis mechanism of MSN-GA-CUR. This mechanism enhanced the cellular uptake of GA-modified nanoparticles, thus increasing the cytotoxicity of MSN-GA-CUR.
In vitro cellular uptake nanoparticles. An abundance of C-6-MSN-GA nanoparticles was internalized by HepG2 cells ( Figure 9A ) due to the specific GA receptor-mediated endocytosis mechanism as mentioned above. However, only a few C-6-MSN nanoparticles were internalized by HepG2 cells (Figure 9B ), which may be attributed to non-specific uptake. Furthermore, consistent with the results of the HPLC method, the uptake of C-6-MSN-GA by HepG2 cells that were pretreated with free GA was significantly lower than that of C-6-MSN-GA alone. This result demonstrated that free GA could reduce the cellular uptake of C-6-MSN-GA by blocking the binding between C-6-MSN-GA and GA receptor.
These results further confirmed the specific GA receptormediated endocytosis mechanism and the cell targeting property of the GA-functionalized formulation.
apoptosis and cell cycle measurement
To study the mechanism of CUR-induced cytotoxicity on HepG2 cells, FCM with FITC-V/PI double staining was employed to investigate cell apoptosis. Apoptosis rate was calculated as the sum of early (Q2) and late apoptosis (Q3). As shown in Figure 10 , 8.1% apoptotic cells were found in the control group, whereas 12.68%, 28.02%, and 42.62% apoptotic cells were found in free CUR, MSN-CUR, and MSN-GA-CUR groups, respectively. The significantly increased apoptosis rate in MSN-GA-CUR treated cells again confirmed that GA-functionalized MSN-GA-CUR highly induced apoptosis in HepG2 cells.
The GA competitive binding assay was also performed. HepG2 cells that were pretreated with free GA exhibited an apoptosis rate of 31.26%, which was lower than that of MSN-GA-CUR alone. These results are in agreement with the results for cellular uptake and cytotoxicity analyses. All observations demonstrated that the GA-functionalized MSN-GA-CUR highly induced apoptosis in HepG2 cells via a specific GA receptor-mediated endocytosis mechanism.
Conclusions
In summary, we exploited MSN-GA to carry CUR for active tumor targeting. MSN-GA not only exhibited a satisfactory loading capacity but also increased drug uptake by GA receptor-positive cells. The successful synthesis of MSN-GA was verified by FTIR, TEM, and zeta potential measurement.
The results of cellular experiments demonstrated that MSN-GA-CUR significantly enhanced cytotoxicity and cellular uptake toward GA-positive tumor cells via a specific GA receptor-mediated endocytosis mechanism. Therefore, the results of this study provide a promising nanoplatform for the targeting of hepatocellular carcinoma.
